TAP
LLY icon

Tounjian Advisory Partners’s Eli Lilly LLY Stock Holding History

Tounjian Advisory Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.9K Sell
58
-3,258
-98% -$3.33M 0.03% 202
2026
Q1 		$3.05M Sell
3,316
-1,204
-27% -$1.22M 1.1% 18
2025
Q4 		$4.86M Buy
4,520
+36
+0.8% +$34.4K 1.65% 11
2025
Q3 		$3.42M Sell
4,484
-52
-1% -$38.7K 1.14% 20
2025
Q2 		$3.75M Sell
4,536
-90
-2% -$69.9K 0.73% 34
2025
Q1 		$3.82M Buy
+4,626
New +$3.85M 0.72% 36

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tounjian Advisory Partners's LLY Position: Q2 2026 in Review

Tounjian Advisory Partners reduced its Eli Lilly (LLY) stake by 98% in Q2 2026, selling an estimated $3.33M and leaving 58 shares worth $69.9K. The position accounts for 0.03% of the portfolio, ranked #202.

Tounjian Advisory Partners first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.86M in Q4 2025. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tounjian Advisory Partners held 58 shares of Eli Lilly worth $69.9K as of Q2 2026.
  • Tounjian Advisory Partners sold 3,258 Eli Lilly shares in Q2 2026, an estimated $3.33M.
  • Eli Lilly made up 0.03% of Tounjian Advisory Partners's portfolio in Q2 2026, its #202 holding.
  • Tounjian Advisory Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • Tounjian Advisory Partners's Eli Lilly position peaked at $4.86M in Q4 2025.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.